an increasing trendP < 0.001
The proportion of adenocarcinoma showed an increasing trend with staining intensity (57.6% in IHC 1 +, 73.5% in IHC 2 +, 87.1% in IHC 3 +; chi-square = 26.7, P < 0.001).
The proportion of adenocarcinoma showed an increasing trend with staining intensity (57.6% in IHC 1 +, 73.5% in IHC 2 +, 87.1% in IHC 3 +; chi-square = 26.7, P < 0.001).
Patients with MET IHC-Positive (2 +/3 +) showed a trend toward MET-TKI benefit.